Luminopia Awarded on TIME’s List of the World’s Top HealthTech Companies 2025
The company was recognized by TIME for reimagining pediatric treatment for lazy eye, the leading cause of vision loss in...
Brain
Theranica Brings First-in-Class, Drug-Free Migraine Care to the Forefront at CNS 2025 with Product Theater and New Real-World Evidence
With a dedicated product theater and new real-world evidence posters, Theranica will spotlight how the Nerivio® REN wearable is reshaping...
Sage Growth Partners Announces New Go-to-Market, Messaging and Sales Enablement Partnership with Xealth
Baltimore-based healthcare growth strategy and marketing firm to provide strategic services and recommendations to help define the next generation of digital...
Apollo Biowellness, Inc., Re-Engages GSS Capital
North Bergen, New Jersey--(Newsfile Corp. - October 8, 2025) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company"), is pleased to...
Nexalin Technology Announces Additional Positive Clinical Results in Alzheimer’s Disease with Gen-2 SYNC Neurostimulation Device
40-Hz DIFS™ significantly improves cognitive performance and brain connectivity in peer-reviewed clinical trial Results published in Radiology, the flagship journal...
Once Upon a Charm Unveils Whimsical New Eyewear That Reimagines Glasses for Girls
The brand stands at the intersection of beauty, advocacy, and healthy vision, blending charming frames with a deeper purpose: empowering...
An Era Where Meditation Becomes a Quantifiable Achievement — Japan’s First “Quantified Meditation Challenge”
TOKYO, Oct. 7, 2025 /PRNewswire/ -- Meditation entered a new era as the World Meditation League (WML), and All Here...
Study Finds Two in Three Women Expect Workplace Menopause Support-Yet Most Say It’s Lacking
Findings reveal critical gaps in employer support—with clear impacts on culture, productivity and retention PORTLAND, Ore., Oct. 7, 2025 /PRNewswire/...
Neurogastrx to Present Proof-of-Concept Clinical Data on Oral Candidate NG101 to Reduce Nausea & Vomiting Associated with GLP-1 Agonists at ObesityWeek®
Nausea and Vomiting Are the Most Frequent Reasons for Discontinuing GLP-1 Therapies, Significantly Impacting Adherence, Titration and Preventing Achievement of Proven...
Albert Einstein College of Medicine Awarded $18 Million NIH Grant to Improve Treatment for Serious Mental Illness
New Predictive Platform Will Use Digital Technology and AI to Assist Clinician Decision-Making BRONX, N.Y., Oct. 6, 2025 /PRNewswire/ -- Serious...
Hyperfine Launches PULSE Platform to Accelerate Adoption and Innovation of AI-Powered Portable MRI
New subscription-based platform empowers a community of Swoop® system users worldwide to access advanced tools in support of imaging research...
Neuropsychiatry Clinical Trials: Evolving with Portable EEG and Digital Endpoints, Upcoming Webinar Hosted by Xtalks
In this free webinar, hear from CNS thought-leaders on the transformative power of objective measures of brain function in neuropsychiatry clinical...
MMI Completes World’s First Robotic Microsurgical Intracranial Brain Surgery
First-in-human cases lay the foundation for the next frontier in robotic microsurgeryJACKSONVILLE, Fla., Oct. 06, 2025 (GLOBE NEWSWIRE) -- MMI...
Biodexa to Host Breakfast Symposium on FAP Mechanisms and Chemoprevention Trial Issues at CGA – IGC Conference on October 11, 2025
October 6, 2025 Biodexa to Host Breakfast Symposium on FAP Mechanisms and Chemoprevention Trial Issues at CGA – IGC Conference...
Gain Therapeutics Presents Initial Data from Phase 1b Clinical Study of GT-02287 in Parkinson’s Patients at International Congress of Parkinson’s Disease and Movement Disorders®
Improvement observed in MDS-UPDRS scores in first 9 participants enrolled; 90-day follow-up continuing in remaining participants Plasma exposures in patients...
Theriva™ Biologics Announces Presentation Describing Next Generation Oncolytic Adenovirus VCN-12 at the 32nd Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
- Preclinical data for VCN-12, the next candidate from Theriva’s VCN-X discovery program, highlight a novel mechanism of action with...
Solana Company (NASDAQ:HSDT), Formerly Helius, Continues Amassing SOL, the Native Asset of Solana Blockchain
NEWTOWN, Pa., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (the "Company" or "HSDT"), today announced its continued...
Eccogene Receives U.S. FDA Clearance to Initiate Phase 2a MOSAIC Trial of ECC4703 and ECC0509 for MASH
BOSTON and SHANGHAI, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Eccogene, a clinical-stage biopharmaceutical company developing next-generation oral small molecule therapeutics...
Contemporary Care Introduces TMS Therapy to Naples, Florida
FDA-approved non-invasive treatment for depression and OCD now available at Contemporary Care’s Naples clinicImage by Contemporary Care NAPLES, Fla., Oct....
Koh Young to Showcase Next Gen Navigated Neurosurgical Robot at CNS Innovation Symposium
Geniant Cranial offers precision, compact footprint, and flexible patient positioning for hospitals seeking to enhance neurosurgical outcomes SAN DIEGO, Oct....